Learn More About The 2026 Summit
Join senior analytical experts across gene therapies to advance QC and potency to drive regulatory approval. Across 3 days, you will gain exclusive insights from leaders the MHRA, Complement Therapeutics, Orchard Therapeutics, UCL, and many more.
Why Analytical Development Has Never Mattered More
Funding headwinds, tighter regulatory expectations, and new EU clinical momentum are reshaping gene therapy. Here’s why robust analytics and potency strategies are now mission-critical.
March 2026
Europe’s Only Dedicated Gene Therapy Analytics Summit
This is a must-attend event for analytical development, QC, CMC, and MSAT leaders, with deep technical sessions, MHRA involvement, and EU benchmarking.
March 2026
Coming Soon
Coming Soon